Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation

GLIA

Volumn 60, Issue 3, 2012, Pages 476-486

  Guardiola Diaz, Hebe M ^a   Ishii, Akihiro ^b   Bansal, Rashmi ^b  

^a TRINITY COLLEGE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Erk MAPK; MTOR; Myelin; Oligodendrocyte

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELIN; RAPAMYCIN;

ARTICLE; DEVELOPMENTAL STAGE; IMMUNOBLOTTING; IN VITRO STUDY; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; MAP KINASE SIGNALING SYSTEM; NERVE TISSUE PROTEINS; O ANTIGENS; OLIGODENDROGLIA; RATS; SIROLIMUS; STEM CELLS; TELENCEPHALON; TOR SERINE-THREONINE KINASES;

EID: 84856208745     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22281     Document Type: Article

References (35)

1. Baas D, Barnstable CJ. 1998. HPC-7: A novel oligodendrocyte lineage protein which appears prior to galactocerebroside. Glia 23: 169-179.
2. Bansal R, Stefansson K, Pfeiffer SE. 1992. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem 58: 2221-2229.
3. Bansal R, Kumar M, Murray K, Morrison RS, Pfeiffer SE. 1996. Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci 7: 263-275.
4. Bansal R, Magge S, Winkler S. 2003. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res 74: 486-493.
5. Baron W, Metz B, Bansal R, Hoekstra D, de Vries H. 2000. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: Regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 15: 314-329.
6. Bhat NR. 1995. Signal transduction mechanisms in glial cells. Dev Neurosci 17: 267-284.
7. Cui QL, Almazan G. 2007. IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases. J Neurochem 100: 1480-1493.
8. Davies SP, Reddy H, Caivano M, Cohen P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
9. Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF. 2003. Regionally specific effects of BDNF on oligodendrocytes. Dev Neurosci 25: 116-26.
10. Du Y, Lercher LD, Zhou R, Dreyfus CF. 2006. Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes. J Neurosci Res 84: 1692-1702.
11. Ebner S, Dunbar M, McKinnon RD. 2000. Distinct roles for PI3K in proliferation and survival of oligodendrocyte progenitor cells. J Neurosci Res 62: 336-345.
12. Emery B. 2010. Transcriptional and post-transcriptional control of CNS myelination. Curr Opin Neurobiol 20: 601-607.
13. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. 2011. Myelin regeneration: A recapitulation of development? Annu Rev Neurosci 34: 21-43.
14. Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, Okamoto T, Macklin WB. 2000. Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci 20: 7622-7630.
15. Flores AI, Narayanan SP, Morse EN, Shick HE, Yin X, Kidd G, Avila RL, Kirschner DA, Macklin WB. 2008. Constitutively active Akt induces enhanced myelination in the CNS. J Neurosci 28: 7174-83.
16. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3: 705-714.
17. Frederick TJ, Min J, Altieri SC, Mitchell NE, Wood TL. 2007. Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-I and FGF-2 requires differential stimulation of multiple signaling pathways. Glia 55: 1011-1022.
18. Frost EE, Zhou Z, Krasnesky K, Armstrong RC. 2009. Initiation of oligodendrocyte progenitor cell migration by a PDGF-A activated extracellular regulated kinase (ERK) signaling pathway. Neurochem Res 34: 169-181.
19. Fyffe-Maricich SL, Karlo JC, Landreth GE, Miller RH. 2011. The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci 31: 843-850.
20. Goebbels S, Oltrogge JH, Kemper R, Heilmann I, Bormuth I, Wolfer S, Wichert SP, Möbius W, Liu X, Lappe-Siefke C, Rossner MJ, Groszer M, Suter U, Frahm J, Boretius S, Nave KA. 2010. Elevated phosphatidylinositol 3, 4, 5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J Neurosci 30: 8953-64.
21. Harrington EP, Zhao C, Fancy SP, Kaing S, Franklin RJ, Rowitch DH. 2010. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann Neurol 68: 703-16.
22. Imamura O, Pages G, Pouyssegur J, Endo S, Takishima K. 2010. ERK1 and ERK2 are required for radial glial maintenance and cortical lamination. Genes Cells 15: 1072-1088.
23. Kondo T, Raff M. 2000. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289: 1754-1757.
24. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
25. Miller RH. 2002. Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 67: 451-467.
26. Narayanan SP, Flores AI, Wang F, Macklin WB. 2009. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci 29: 6860-6870.
27. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3: 191-197.
28. Tang DG, Tokumoto YM, Raff MC. 2000. Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. J Cell Biol 148: 971-984.
29. Tyler WA, Gangoli N, Gokina P, Kim HA, Covey M, Levison SW, Wood TL. 2009. Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J Neurosci 29: 6367-6378.
30. Tyler WA, Jain MR, Cifelli SE, Li Q, Ku L, Feng Y, Li H, Wood TL. 2011. Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiation. Glia 59: 1754-69.
31. Van't Veer A, Du Y, Fischer TZ, Boetig DR, Wood MR, Dreyfus CF. 2009. Brain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway. J Neurosci Res 87: 69-78.
32. Warrington AE, Barbarese E, Pfeiffer SE. 1993. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res 34: 1-13.
33. Yim SH, Hammer JA, Quarles RH. 2001. Differences in signal transduction pathways by which platelet-derived and fibroblast growth factors activate extracellular signal-regulated kinase in differentiating oligodendrocytes. J Neurochem 76: 1925-1934.
34. Younes-Rapozo V, Felgueiras LO, Viana NL, Fierro IM, Barja-Fidalgo C, Manhaes AC, Barradas PC. 2009. A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro: Stage specific effects on cell branching. Int J Dev Neurosci 27: 757-768.
35. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.